Torrey Growth & Income Advisors

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 2087822 DEL MAR, CA

Position in VRTX

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$2,339,598

+$236,395 QoQ

Shares Held

4,710

0.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.84%

of 13F equity value

Holder Rank

#631

of 1,745 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Torrey Growth & Income Advisors holds $6,964,754 across 5 Biotechnology names. VRTX ranks #1 (33.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	4,710	$2,339,598
2	VCEL	Vericel Corp	38,308	$1,704,322
3	NTLA	Intellia Therapeutics, Inc.	70,669	$1,195,719
4	IBRX	ImmunityBio, Inc.	118,860	$1,040,619
5	CADL	Candel Therapeutics, Inc.	66,456	$684,496

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,339,598	4,710	0.0%	Shares	Sole	2026-07-27
2026-03-31	$2,103,203	4,710	-0.2%	Shares	Sole	2026-04-21
2025-12-31	$2,139,405	4,719	-12.6%	Shares	Sole	2026-02-17
2025-09-30	$2,114,856	5,400	—	Shares	Sole	2025-11-13
No filing history on record for this holder in this stock.